CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 83 enrolled
Drug / intervention
Metal-on-Metal Articulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03382652
NCT03382652N/ACompleted

Continuum™ Metal Bearing System in Total Hip Arthroplasty- A Multi-center, Prospective, Non-controlled Post Market Surveillance Study

Zimmer Biomet·observational·Posted Dec 26, 2017·Updated Jan 3, 2025

In Brief

An observational study evaluating Metal-on-Metal Articulation for Avascular Necrosis and 4 related conditions. Completed, enrolled 83 participants across 3 sites in 2 countries.

Detailed Summary

The study is a multi-center, prospective, non-controlled, consecutive cohort post market surveillance study. The objective of this study is to obtain survival and outcome data on the Continuum Metal Bearing System in primary total hip arthroplasty.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFinland, United States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 26, 2017
Enrollment StartFeb 9, 2011
Primary CompletionOct 22, 2022
TodayJul 2, 2026
Enrollment to primary: 11.7 yearsPosted 8.5 years ago

Interventions

Metal-on-Metal Articulationdevice

\<Metal-on-Metal Articulation\>: Metasul® Taper Liner and Metasul Femoral Head, \<Acetabular Component\>:Continuum Acetabular Shell, \<Femoral Component\>: Zimmer® M/L Taper Hip Stem